Alles Mark J 4
4 · Syros Pharmaceuticals, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Alles Mark J
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-08+17,500→ 17,500 totalExercise: $6.30Exp: 2031-06-07→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.